Neuren Pharmaceuticals Limited (NURPF)
Market Closed
14 Oct, 08:00 PM
OTC PINK 
$
14. 28
0
0%
$
1.12B Market Cap
- P/E Ratio
- Div Yield
265 Volume
- Eps
$ 14.28
Previous Close Want to track NURPF and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Neuren Pharmaceuticals Limited (NURPF) Statistics
Valuation metrics
Market Cap 1.12B
Enterprise value 2.53B
Trailing P/E (ttm) 127.61
Forward P/E -
PEG ratio -1.48
Price/Sales (ttm) 36.84
Price/Book (mrq) 7.68
Enterprise Value/Revenue 36.45
Enterprise Value/EBITDA 182.65
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 50
Average volume (90 days) 514
Price summary
52-Week low 7.7
52-Week high 17.25
Beta -
50-Day moving average 15.12
200-Day moving average 11.71
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate 0.15
Trailing annual dividend yield 0.0074%
5-Year annual dividend yield -
Payout ratio -
Dividend Date 7 Oct 2026
Ex-Dividend Date 15 Sep 2026
Last split factor 1:20
Last split Date 21 Nov 2017
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin 0.29%
Operating margin 0.2%
Operational effectiveness
Return on assets 0.06%
Return on equity 0.06%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 0.55
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) 0.16
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 2.26
Total debt (mrq) -
Total Debt/Equity (mrq) -
Current ratio (mrq) 46.45%
Book value per share (mrq) 2.63
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
2026 © Marketlog. All Rights Reserved.
